This paper is only available as a PDF. To read, Please Download here.
Insulin rapidly lowers serum insulin-like growth factor-binding protein-1 (IGFBP-1) levels in vivo. In studies reported here, HEP G2 cells were used as a model system to investigate how insulin achieves this effect. When HEP G2 cells were incubated with 100 nM insulin for 6, 14, or 24 h, IGFBP-1 protein levels in conditioned medium fell to approximately 50% of control values. This apparently was due to a fall in the rate of IGFBP-1 protein synthesis, since HEP G2 cells incorporated 46% less [35S]methionine into IGFBP-1 during a 4-h incubation with 100 nM insulin. IGFBP-1 mRNA levels were similarly affected by 100 nM insulin, falling to 45% of control values after 2 h, and to 9% of control values after 4 h of incubation with this hormone. The fall in IGFBP-1 mRNA level is consistent with data from nuclear transcription assays. HEP G2 nuclei isolated from cells that were incubated with 100 nM insulin for 2 h synthesized only approximately 1/3 the number of IGFBP-1 transcripts as did control nuclei. Further evidence that insulin decreases IGFBP-1 gene transcription comes from transient transfections using chimeric IGFBP-1 promoter-chloramphenicol acetyltransferase reporter gene constructs. IGFBP-1 promoter activity fell to approximately 50% of control values when HEP G2 cells transfected with a construct containing the first 1205 base pairs of the IGFBP-1 promoter were incubated with 100 nM insulin for 6, 14, or 24 h. Insulin lowered both IGFBP-1 protein levels and promoter activity in a dose-dependent manner. A half-maximal effect was found at approximately 1 nM insulin and a maximal effect was found at approximately 10 nM insulin in each instance. Transfections with constructs containing smaller IGFBP-1 promoter fragments showed that the region spanning from 103 to 529 base pairs 5' to the IGFBP-1 mRNA cap site was necessary to demonstrate the inhibitory effect of insulin. These studies indicate that insulin lowers IGFBP-1 protein levels, at least in part, by rapidly decreasing the rate of IGFBP-1 gene transcription, and suggest that this insulin-mediated fall in transcription is conferred through a specific region of the IGFBP-1 promoter.
References
- Prog. Growth Factor Res. 1989; 1: 49-68
- Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 8338-8342
- FEES Lett. 1989; 255: 253-258
- Endocrinology. 1988; 122: 2150-2157
- Endocrinology. 1989; 124: 2289-2296
- J. Clin. Endocrinol. Metab. 1990; 70: 173-180
- Endocrinology. 1990; 127: 2795-2803
- Proc. Natl. Acad. Sci. U. S. A. 1987; 84: 3254-3258
- J. Clin. Endocrinol. Metab. 1984; 59: 908-915
- J. Clin. Endocrinol. Metab. 1987; 65: 432-440
- Diabetes. 1990; 39: 1251-1256
- Clin. Endocrinol. 1988; 29: 667-675
- J. Clin. Endocrinol. Metab. 1988; 67: 882-887
- J. Clin. Endocrinol. Metab. 1988; 66: 266-272
- J. Clin. Endocrinol. Metab. 1988; 67: 1225-1230
- Acta Endocrinol. 1988; 119: 465-473
- J. Endocrinol. Invest. 1988; 11: 599-602
- J. Clin. Endocrinol. Metab. 1989; 69: 246-252
- J. Clin. Endocrinol. Metab. 1990; 70: 1062-1067
- Mol. Endocrinol. 1990; 4: 321-328
- Endocrinology. 1990; 126: 2614-2624
- In Vitro. 1989; 25: 217-222
- J. Chromatogr. 1987; 420: 163-170
- Drop S.L.S. Hintz R.L. Insulin-like Growth Factor Binding Proteins. Elsevier Science Publishers B. V., Amsterdam1989: 3-8
- J. Biol. Chem. 1990; 265: 21185-21193
- J. Biol. Chem. 1989; 264: 17623-17626
- Biotechniques. 1988; 6: 454-457
- Virology. 1973; 52: 456-467
- Mol. Cell Biol. 1987; 7: 725-737
- Mol. Cell. Biol. 1982; 2: 1044-1051
- Mol. Endocrinol. 1989; 3: 846-851
- J. Biol. Chem. 1990; 265: 12642-12649
- Pediatr. Res. 1989; 26: 308-315
- J. Clin. Endocrinol. Metab. 1990; 70: 620-628
- Antibodies. 1st ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY1988: 139-281
- Mol. Cell. Biol. 1981; 1: 289-301
- Mol. Endocrinol. 1988; 2: 404-411
- Cell. 1980; 20: 95-105
- Biochem. J. 1983; 214: 845-850
- J. Biol. Chem. 1986; 261: 9721-9726
- Mol. Endocrinol. 1990; 4: 1592-1599
- Mol. Endocrinol. 1990; 4: 1199-1204
- J. Biol. Chem. 1988; 263: 16580-16585
- Science. 1990; 249: 533-537
- J. Biol. Chem. 1984; 259: 15242-15251
- J. Biol. Chem. 1987; 262: 14917-14920
- Diabetes. 1980; 29: 487-496
- Mol. Cell. Endocrinol. 1989; 63: 199-208
- Mol. Cell. Biol. 1990; 10: 4712-4719
- Trends Endocrinol. Metab. 1990; 1: 347-351
Article info
Publication history
Published online: October 05, 1991
Identification
Copyright
© 1991 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
User license
Creative Commons Attribution (CC BY 4.0) | How you can reuse
Elsevier's open access license policy

Creative Commons Attribution (CC BY 4.0)
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy